Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of KK6483C With Levodopa/Carbidopa/Entacapone in Healthy Male Volunteers
jRCT2051200104Phase 1Completed
- Sponsor
- Kyowa Kirin
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of KK6483C in Parkinson's disease (PD), sponsored by Kyowa Kirin. Primary endpoints: Plasma drug concentration of KK6483C (and/or co-administered drugs) and Pharmacokinetic parameters. Started Jan 2021; status: completed.
02
Drugs
KK6483C
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2051200104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051200104.